abstract |
The present invention provides a target Factor VIII molecule comprising Factor VIII linked to at least one domain of a membrane protein that specifically binds to red blood cells. The disclosed target coagulation factors prolong the duration of their effects and thus enhance the treatment of blood diseases such as hemophilia A. |